Phylodynamics of SARS-CoV-2 in France, Europe, and the world in 2020.

COVID-19 France SARS-CoV-2 epidemiology evolutionary biology genomic epidemiology global health maximum likelihood phylodynamics viruses

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
26 04 2023
Historique:
received: 08 08 2022
accepted: 15 04 2023
medline: 15 5 2023
pubmed: 9 5 2023
entrez: 9 5 2023
Statut: epublish

Résumé

Although France was one of the most affected European countries by the COVID-19 pandemic in 2020, the dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) movement within France, but also involving France in Europe and in the world, remain only partially characterized in this timeframe. Here, we analyzed GISAID deposited sequences from January 1 to December 31, 2020 (

Identifiants

pubmed: 37159510
doi: 10.7554/eLife.82538
pii: 82538
pmc: PMC10179682
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023, Coppée et al.

Déclaration de conflit d'intérêts

RC, FB, AJ, VL, VF, AF, LD, CC, SL, KZ, VC, DD, AM, BV, AB No competing interests declared

Références

Nature. 2021 Jul;595(7869):713-717
pubmed: 34192736
Mol Biol Evol. 2021 Apr 13;38(4):1608-1613
pubmed: 33316043
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Nat Rev Genet. 2022 Sep;23(9):547-562
pubmed: 35459859
Mol Biol Evol. 2010 Sep;27(9):1988-99
pubmed: 20368266
Nat Med. 2020 Sep;26(9):1417-1421
pubmed: 32665655
Nat Hum Behav. 2021 Apr;5(4):529-538
pubmed: 33686204
BMC Evol Biol. 2007 Nov 08;7:214
pubmed: 17996036
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
BMJ. 2020 Oct 23;371:m3862
pubmed: 33097561
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):
pubmed: 33571105
Trends Ecol Evol. 1998 Sep 1;13(9):361-6
pubmed: 21238344
Glob Health Res Policy. 2017 May 08;2:13
pubmed: 29202081
Bioinformatics. 2004 Jan 22;20(2):289-90
pubmed: 14734327
Euro Surveill. 2020 Feb;25(6):
pubmed: 32070465
PLoS Comput Biol. 2013;9(3):e1002947
pubmed: 23555203
Syst Biol. 2016 Jan;65(1):82-97
pubmed: 26424727
China CDC Wkly. 2021 Dec 3;3(49):1049-1051
pubmed: 34934514
Mol Biol Evol. 2000 Jun;17(6):890-6
pubmed: 10833195
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
Int J Antimicrob Agents. 2020 Jun;55(6):106006
pubmed: 32371096
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Virus Evol. 2016 Mar 02;2(1):vew003
pubmed: 27774296
Euro Surveill. 2020 Jul;25(26):
pubmed: 32643599
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Elife. 2022 Aug 02;11:
pubmed: 35916373
Nature. 2020 Oct;586(7830):516-527
pubmed: 32967006
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Mol Biol Evol. 2020 Feb 1;37(2):599-603
pubmed: 31633786
Rev Francoph Lab. 2020 Nov;2020(526):57-62
pubmed: 33163105
Sustain Prod Consum. 2021 Apr;26:343-359
pubmed: 33072833
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823

Auteurs

Romain Coppée (R)

Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.

François Blanquart (F)

Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Centre for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS Inserm, PSL Research University, Paris, France.

Aude Jary (A)

Sorbonne Université, Inserm, iPLESP, Paris, France.

Valentin Leducq (V)

Sorbonne Université, Inserm, iPLESP, Paris, France.

Valentine Marie Ferré (VM)

Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Service de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

Anna Maria Franco Yusti (AM)

Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Service de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

Léna Daniel (L)

Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Service de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

Charlotte Charpentier (C)

Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Service de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

Samuel Lebourgeois (S)

Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Service de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

Karen Zafilaza (K)

Sorbonne Université, Inserm, iPLESP, Paris, France.
Service de Virologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France.

Vincent Calvez (V)

Sorbonne Université, Inserm, iPLESP, Paris, France.
Service de Virologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France.

Diane Descamps (D)

Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Service de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

Anne-Geneviève Marcelin (AG)

Sorbonne Université, Inserm, iPLESP, Paris, France.
Service de Virologie, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France.

Benoit Visseaux (B)

Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Service de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

Antoine Bridier-Nahmias (A)

Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH